Recovery Support
Neuropathy & Nerve Repair Research Protocol
Educational protocol for compounds studied in peripheral and central nervous system repair and neuroprotection
• This protocol is provided for educational and informational purposes only. It does not constitute medical advice, a diagnosis, a treatment plan, or a prescription.
• All dose ranges, frequencies, durations, and compound selections must be determined by a licensed healthcare professional based on your individual medical history, lab results, and clinical assessment.
• Lab monitoring may be required depending on the compound(s), individual health status, and duration of use. Discuss appropriate monitoring protocols with your clinician.
• Do not use any peptide compound if you are pregnant, breastfeeding, a minor, or have uncontrolled medical conditions without explicit direction from your physician.
High Risk — Specialist Supervision Required
Significant safety considerations; not suitable for unsupervised use
Overview
This educational protocol covers research discussion points for compounds studied in the context of peripheral neuropathy, nerve repair, and neuroprotection. Given the involvement of nerve growth factor (a pleiotropic signalling molecule) and the experimental nature of most compounds in this area, this protocol has a HIGH RISK designation requiring specialist neurological oversight.
Mechanism Summary
BPC-157 has been studied for upregulation of the VEGF-FAK-paxillin pathway and nitric oxide system, with observed peripheral nerve regeneration effects in sciatic nerve injury models. Thymosin Beta-4 is an actin-sequestering peptide with documented roles in promoting oligodendrocyte differentiation and axonal remyelination in CNS injury research. NGF is the prototype neurotrophic factor, signalling through TrkA and p75NTR receptors to promote sensory and sympathetic neuron survival; systemic NGF is associated with significant musculoskeletal pain as a side effect.
Intended Goal
Prepare for a specialist clinician consultation on peptide compounds studied in nerve repair, neuroprotection, and neuropathy research contexts
BPC-157
Neuroprotective / nerve regeneration / cytoprotective
Studied for peripheral nerve regeneration and neuroprotective effects in animal models. Catalog reference.
TB-500 (Thymosin Beta-4)
Actin regulation / neuroregeneration / CNS repair
Studied for CNS and peripheral nerve repair properties, including potential roles in oligodendrocyte and axon regeneration. Catalog reference.
NGF (Nerve Growth Factor)
Neurotrophic factor / nerve survival / pain research
Endogenous neurotrophic factor critical for sensory and sympathetic neuron survival. Studied in neuropathy and Alzheimer's research. High risk — systemic administration associated with significant pain. Catalog reference.
Research reference values only. Confirm all parameters with current literature and your clinician.
Who may be a candidate
- ✓Adults with clinician-confirmed peripheral neuropathy under neurologist care
- ✓Individuals post-nerve injury under specialist rehabilitation management
- ✓Patients in a clinical research context investigating neurotrophic compounds
Exclusions
- ✕Not appropriate without active neurologist or specialist physician oversight
- ✕Not appropriate for self-directed neuropathy management
- ✕Not appropriate for acute spinal cord injuries without specialist trauma care
What type of neuropathy do I have and which compounds are most relevant to that mechanism?
How would you assess nerve regeneration progress objectively?
What is your experience with peptide compounds in neuropathy management?
How do you weigh the pain risk of NGF against potential nerve repair benefits?
Print or copy these questions using the "Copy Summary" button to bring to your appointment.
Legal & Compliance Notice
BPC-157, TB-500, and research-grade NGF are not approved for therapeutic use. Verify all compound regulatory statuses with a licensed clinician.
The legal and regulatory status of research compounds varies by country and jurisdiction. It is the user's responsibility to understand applicable local laws before engaging with any compound.
This application does not provide personalized dosing recommendations. Users who require medical guidance should consult a qualified clinician.
Last reviewed: 2025-03-01 · Status: reviewed
Discuss with Your Clinician
Use this protocol as a research starting point. A qualified healthcare professional can review your health history, order appropriate labs, and help you determine what approach — if any — makes sense for your specific situation.